Vaginal pH imbalance, commonly associated with BV-like dysbiosis, leads to malodor, discomfort, and altered mucosal hydration. The underlying mechanism is a shift toward a more alkaline environment (>4.5), which promotes anaerobic bacterial growth and amine production responsible for odor.

Two main intravaginal delivery systems are used to restore physiological acidity: gels and ovules. While both can effectively lower vaginal pH and reduce odor, they differ mainly in kinetics and mucosal tolerability rather than overall efficacy.

Vaginal gels

Gels are aqueous systems containing lactic acid, lactate buffers, and humectants. Their action is based on rapid diffusion into vaginal fluids, producing a fast biochemical response.

Advantages

• Rapid onset of action (typically within a few hours)
• Immediate sensation of moisture and freshness
• Homogeneous distribution of active ingredients

Limitations

• Higher variability in tolerability due to osmotic load (e.g., glycerin, propylene glycol)
• Potential transient irritation or “acid sting” in sensitive mucosa
• Shorter residence time and less sustained environmental control

Gels are therefore characterized by a fast initial response, but their effect tends to be more dependent on formulation variables and local conditions.

Vaginal ovules

Ovules are lipid-based controlled-release systems, often combined with lactic acid and mucoadhesive polymers such as polycarbophil. Their mechanism is based on gradual melting and sustained release within the vaginal environment.

Advantages

• Superior mucosal tolerability due to gradual acid exposure
• Reduced risk of irritation or acid shock
• Sustained and stable pH support over time (up to 48–72 hours in mucoadhesive systems)
• More consistent performance across sensitive or inflamed mucosa

Limitations

• Slightly slower onset compared to gels (difference of hours, not days)
• Possible transient residue due to lipid base

Importantly, the slower onset is generally not clinically relevant, as both systems act within a short time window relative to the underlying condition.

Comparison

Odor control (amine neutralization)

Hydration and comfort

Irritation profile

Key mechanistic insight

The fundamental difference is not speed, but exposure profile:

• Gels act through rapid diffusion and immediate environmental shift
• Ovules act through controlled release and sustained mucosal interaction

The few-hour difference in onset is secondary compared to the impact of tolerability, residence time, and stability of the vaginal ecosystem.

Conclusion

Although vaginal gels can provide a slightly faster initial response, this difference is clinically marginal in the context of vaginal pH restoration, where both systems act within hours.

Ovules offer a more balanced and physiologically compatible approach: they combine effective acidification with controlled release, lower irritation risk, and longer-lasting stabilization of the vaginal environment.

For this reason, ovules are generally the more robust and reliable option across most clinical scenarios, particularly in sensitive, inflamed, or recurrent conditions where mucosal tolerance and consistency of effect are more important than marginal differences in onset speed.

In practical terms, gels prioritize immediacy, while ovules prioritize physiological compatibility and sustained efficacy—making them the preferred choice in most real-world applications.

References

• Lactic acid in vaginal microbiota and antimicrobial function
• Clinical effects of lactic-acid vaginal gels on microbiota and pH
• Cytotoxicity and epithelial impact of OTC lactic acid gels (in vitro)
• Polycarbophil-based vaginal systems (ovules/gel comparison)